1.19 USD
▲+0.14+13.33%
盘后 1.24 0.00%
2026-09-16
市值
$27.34M
市盈率
—
EPS
-0.43
股息率
—
52 周区间
0.85 – 2.23
成交量
1.12M
Beta
1.66
目标价
6.00
52W 低 0.8552W 高 2.23
价格走势
公司简介
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company’s product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies developed for the treatment of COVID infection...